Davidson Kempner Capital Management’s Revolution Medicines Inc Warrant RVMDW Stock Holding History

Davidson Kempner Capital Management’s Portfolio RVMDW Stock Details RVMDW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-150,000	Closed	-$261K	–	282
2026 Q1	$261K	Hold	150,000	–	–	﹤0.01%	191
2025 Q4	$141K	Hold	150,000	–	–	﹤0.01%	182
2025 Q3	$45K	Hold	150,000	–	–	﹤0.01%	207
2025 Q2	$39.4K	Hold	150,000	–	–	﹤0.01%	172
2025 Q1	$5.7K	Hold	150,000	–	–	﹤0.01%	198
2024 Q4	$27K	Hold	150,000	–	–	﹤0.01%	180
2024 Q3	$21K	Hold	150,000	–	–	﹤0.01%	172
2024 Q2	$10.5K	Hold	150,000	–	–	﹤0.01%	223
2024 Q1	$28.5K	Hold	150,000	–	–	﹤0.01%	205
2023 Q4	$49.5K	Buy	+150,000	New	+$67K	﹤0.01%	170

Other funds holding RVMDW

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Caption Management Oklahoma City, Oklahoma $21.5B AUM 81.81% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

Davidson Kempner Capital Management's RVMDW Position: Q2 2026 in Review

Davidson Kempner Capital Management sold out of Revolution Medicines Inc Warrant (RVMDW) in Q2 2026, closing a stake of 150,000 shares — an estimated $261K sold.

Davidson Kempner Capital Management first reported a position in RVMDW in Q4 2023 and held it in 10 quarters. The position peaked at $261K in Q1 2026. 22 funds tracked by Wall St. Rank hold RVMDW as of Q2 2026.

Davidson Kempner Capital Management reported no remaining Revolution Medicines Inc Warrant position as of Q2 2026 after selling out during the quarter.
Davidson Kempner Capital Management sold 150,000 Revolution Medicines Inc Warrant shares in Q2 2026, an estimated $261K.
Davidson Kempner Capital Management first reported a position in Revolution Medicines Inc Warrant in Q4 2023 and held it in 10 quarters.
Davidson Kempner Capital Management's Revolution Medicines Inc Warrant position peaked at $261K in Q1 2026.
22 funds tracked by Wall St. Rank held Revolution Medicines Inc Warrant as of Q2 2026.

Based on Davidson Kempner Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.